CSPG4 and neoplasm: Shoshan and co-workers demonstrated NG2 expression in one out of five GBMs by immunoblotting [8], whilst we showed moderate to high expression in 6 out of 14 GBM biopsies from the tumour mass and confrontation edge by immunohistochemistry [5].